JAGX Earnings Jaguar Health, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | -35.11 | 2026-08-19 | 10-Q |
| Q1 2026 | 2026-03-31 | -13.60 | 2026-05-20 | 10-Q |
| FY 2025 | 2025-12-31 | -22.97 | 2026-04-07 | 10-K |
| Q3 2025 | 2025-09-30 | -22.61 | 2025-11-14 | 10-Q |
| Q2 2026 | 2025-06-30 | -937.26 | 2026-08-19 | 10-Q |
| Q1 2026 | 2025-03-31 | -584.45 | 2026-05-20 | 10-Q |
| FY 2025 | 2024-12-31 | -130.69 | 2026-04-07 | 10-K |
| Q3 2025 | 2024-09-30 | -150.72 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -7.80 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -87.12 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -2678.17 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -132.49 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -128.12 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -2.39 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -36.18 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -36.62 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -29.51 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -23.10 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -88.22 | 2023-03-24 | 10-K |
| Q3 2022 | 2021-09-30 | -0.87 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.60 | 2022-08-22 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.28 | 2022-05-10 | 10-Q |
| FY 2021 | 2020-12-31 | -3.00 | 2022-03-11 | 10-K |
| Q3 2021 | 2020-09-30 | -3.09 | 2021-11-17 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.97 | 2021-08-13 | 10-Q |
| Q3 2018 | 2018-09-30 | -1.91 | 2018-11-19 | 10-Q |
| Q3 2018 | 2017-09-30 | -0.94 | 2018-11-19 | 10-Q |
| Q3 2017 | 2016-09-30 | -1.07 | 2017-11-20 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.